Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

58.96
Delayed Data
As of Jul 31
 +0.44 / +0.75%
Today’s Change
52.49
Today|||52-Week Range
63.62
+3.82%
Year-to-Date

Today’s Trading

Previous close58.52
Today’s open59.00
Day’s range58.70 - 59.33
Volume8,752,452
Average volume (3 months)9,421,996
Market cap$166.6B
Dividend yield3.05%
Data as of 4:04pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+176.87%
Earnings growth (this year)+0.09%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-4.48%
P/E ratio15.3
Price/Sales3.95
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.42+0.78%
AGNAllergan+2.28+0.69%
NVONovo Nordisk+0.68+1.17%
ABBVAbbVie-0.15-0.21%
Data as of 4:05pm ET, 07/31/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)$0.91
Annual revenue (last year)$42.1B
Annual profit (last year)$11.9B
Net profit margin28.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts